Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel M Verbeek

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
JAMA Neurology|June 18, 2019
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysisClaire Bridel, Wessel N van Wieringen, Henrik Zetterberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 22, 2021
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overviewConstance Delaby, Charlotte E Teunissen, Kaj Blennow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
JAMA Neurology|June 18, 2019
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysisClaire Bridel, Wessel N van Wieringen, Henrik Zetterberg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
JAMA|May 20, 2015
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysisWillemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, et al.
JAMA Neurology|January 31, 2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical SpectrumWillemijn J Jansen, Olin Janssen, Betty M Tijms, et al.
Pageof 24